A recent pilot study published in The New England Journal of Medicine reveals that a single gene-editing treatment using CRISPR technology can reduce cholesterol levels by approximately 50% over a year without adverse effects. The study involved a small group of participants and…
A recent study published in the New England Journal of Medicine highlights a promising CRISPR-based gene-editing therapy that may serve as a one-time treatment for individuals wit…
A recent study published in PNAS indicates that folic acid may aid in preventing neural tube defects by supporting the body's production of retinoic acid, a vital form of vitamin…
Researchers are making significant strides in epigenetic editing, a technique that modifies chemical tags on DNA to influence gene expression without altering the genetic code its…
Scribe Therapeutics experienced a significant surge in its stock price, climbing approximately 67% on its first day of trading on the Nasdaq after raising $128.7 million in its in…